Adial Applauds New Path for Substance Use Disorder Trials
Congress’s 2026 appropriations package for HHS embeds a clear directive: FDA and NIDA are to collaborate on alternative clinical...
Pivotal DEVOTE Study Results on High-Dose Nusinersen in SMA
Treatment-naïve infants with SMA receiving Biogen’s higher-dose nusinersen regimen achieved a 26.19-point advantage on CHOP-INTEND versus a prespecified matched...
How Early-Stage Intelligence Determines Late-Stage Success
Why competitive insight in the earliest stages of developing a therapy can determine ultimate success By Alex Angelopoulos, Life...
Breaking the Transcription Barrier: How eSource Redefines Clinical Research Workflows
The traditional clinical trial landscape is undergoing a digital metamorphosis. For decades, the reliance on manual transcription—moving data from...
First Patient Enrolled in Japan Prostate Cancer Trial
Global Phase 3 data for 177Lu‑PSMA‑I&T have met the primary endpoint with statistically significant, clinically meaningful benefit in metastatic...
BioStem Aligns with FDA’s Bayesian Clinical Trial Approach
In a randomized study of diabetic foot ulcers, BioStem’s BioRetain-processed allografts were reported to be nearly twice as likely...
Neomorph Doses First Patient in NEO-811 Cancer Trial
Neomorph has opened dosing in its first-in-human Phase 1/2 study of NEO-811, an oral, cereblon-dependent molecular glue degrader being...
Theriva to Present VCN-01 Retinoblastoma Trial Data at APAO
Theriva Biologics will present safety and clinical outcomes from an investigator-sponsored Phase 1 study of intravitreal VCN-01 (zabilugene almadenorepvec)...
BioCardia to Present Late-Breaking CardiAMP HF Trial Data
No efficacy or safety numbers were disclosed. BioCardia’s CardiAMP autologous cell therapy will be featured as a Late Breaking...
Radical Acceleration: Transforming Clinical Research Timelines Through AI and Systems Integration
At the 2026 SCOPE Summit, industry veterans and technology leaders convened to address a staggering economic reality: the cost...